Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 285

1.

Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.

Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, Nadler RB.

JAMA. 1995 Oct 18;274(15):1214-20.

PMID:
7563511
2.

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, deKernion JB, Walsh PC, Scardino PT, Lange PH, Subong EN, Parson RE, Gasior GH, Loveland KG, Southwick PC.

JAMA. 1998 May 20;279(19):1542-7.

PMID:
9605898
4.

Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.

Martínez-Piñeiro L, Tabernero A, Contreras T, Madero R, Lozano D, López-Tello J, Alonso-Dorrego JM, Picazo ML, González Gancedo P, Martínez-Piñeiro JA, de La Peña JJ.

Eur Urol. 2000 Mar;37(3):289-96.

PMID:
10720854
5.

Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening.

Reissigl A, Klocker H, Pointner J, Fink K, Horninger W, Ennemoser O, Strasser H, Colleselli K, Höltl L, Bartsch G.

Urology. 1996 Dec;48(6A Suppl):62-6.

PMID:
8973702
6.

Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.

Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M.

J Urol. 2000 Apr;163(4):1144-8; discussion 1148-9.

PMID:
10737484
7.

[Value of free/total prostate specific antigen in the early diagnosis of prostate cancer (study of 105 patients)].

de la Taille A, Houlgatte A, Houdelette P, Berlizot P, Ramirez J, Ricordel I.

Prog Urol. 1997 Apr;7(2):240-5. French.

PMID:
9264766
8.

Prostate carcinoma screening in the county of Tyrol, Austria: experience and results.

Reissigl A, Horninger W, Fink K, Klocker H, Bartsch G.

Cancer. 1997 Nov 1;80(9):1818-29.

PMID:
9351555
9.

Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen.

Luderer AA, Chen YT, Soriano TF, Kramp WJ, Carlson G, Cuny C, Sharp T, Smith W, Petteway J, Brawer MK, et al.

Urology. 1995 Aug;46(2):187-94.

PMID:
7542820
10.

Percent free PSA as an additional measure in a prostate cancer screen.

Miele ME.

Clin Lab Sci. 2001 Spring;14(2):102-7.

PMID:
15625982
11.

A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenario.

Prestigiacomo AF, Lilja H, Pettersson K, Wolfert RL, Stamey TA.

J Urol. 1996 Aug;156(2 Pt 1):350-4.

PMID:
8683677
12.

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

Catalona WJ, Southwick PC, Slawin KM, Partin AW, Brawer MK, Flanigan RC, Patel A, Richie JP, Walsh PC, Scardino PT, Lange PH, Gasior GH, Loveland KG, Bray KR.

Urology. 2000 Aug 1;56(2):255-60.

PMID:
10925089
13.

Probability of prostate cancer as a function of the percentage of free prostate-specific antigen in patients with a non-suspicious rectal examination and total prostate-specific antigen of 4-10 ng/ml.

Martínez-Piñeiro L, García Mediero JM, González Gancedo P, Tabernero A, Lozano D, López-Tello JJ, Alonso-Dorrego JM, Núñez C, Picazo ML, Madero R, De La Peña JJ.

World J Urol. 2004 Jun;22(2):124-31.

PMID:
14986047
14.

Clinical usefulness of free PSA in early detection of prostate cancer.

Luboldt HJ, Swoboda A, Börgermann C, Fornara P, Rübben H; Early Detection Project Group of the German Society of Urology..

Onkologie. 2001 Feb;24(1):33-7.

PMID:
11441278
15.

Evaluation of prostAsure index in the detection of prostate cancer: a preliminary report.

Babaian RJ, Fritsche HA, Zhang Z, Zhang KH, Madyastha KR, Barnhill SD.

Urology. 1998 Jan;51(1):132-6.

PMID:
9457308
18.

Optimum PSA reflex-range.

Benecchi L.

Arch Ital Urol Androl. 2006 Jun;78(2):44-8.

PMID:
16929601
19.

The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.

Ramos CG, Carvahal GF, Mager DE, Haberer B, Catalona WJ.

J Urol. 1999 Nov;162(5):1587-90.

PMID:
10524873
20.

Supplemental Content

Support Center